Work

Abstract 363: CYT01B, a novel RAD51 inhibitor, acts synergistically with PARP inhibitors

Year: 2019

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2019-363

Authors: Tyler Maclay, Melinda Day, Kevin Mills

Institution: Cyteir Therapeutics (United States)

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2955280685

Cites:

Cited by: 5

Related to: 10